CCO Annual Report (2016) Editorial Office editor@thecco.net
Outline of the Report 1.Basic Information 2.Message from the Editors-in-Chief 3.Distribution of Editorial Board Members 4.Number of Published Articles (results by year) 5.Diverse Types of Article Published in 2016 6.International Diversity of Corresponding Authors in 2016 7.Citations in 2016 (results by month) 8.Website Visits in 2016 9.Most Cited Articles Published in 2016 10.Focused Issues Published in 2016 11.Upcoming Focused Issues in 2017 12.International Meeting 13.Introduction of the Publisher AME
1. Basic Information 2012: Launched in Sep. 2013: Indexed in MDlinx, Medscape 2013: Endorsed by CSCO 2014: Indexed in MEDLINE/PubMed 2015: Indexed in Scopus 2016: Published Bimonthly 2016: Indexed in ESCI The journal provides current and practical information on basic research and clinical investigations n the field of oncology.
2. Message from the Editors-in-Chief On behalf of the editorial team, we would like to express sincere appreciation for the enthusiastic and vigorous support and contributions from all editorial board members, guest editors, authors, reviewers and readers etc. Shukui Qin, MD, PhD Director of Cancer Center of Chinese PLA, Executive member of the Asian Clinical Oncology Society (ACOS), Chair of Chinese Society of Clinical Oncology (CSCO) Jiade J. Lu, MD, MBA Professor of Clinical Oncology Fudan University, School of Medicine, Executive Vice President of Shanghai Proton and Heavy Ion Center (SPHIC), The Proton and Heavy Ion Center of Fudan University Charles M Balch, MD, FACS Professor of Surgery, Department of Surgical Oncology University of Texas MD Anderson Cancer center, Houston, Texas and Professor of Surgery Division of Surgical Oncology Department of Surgery University of Texas Southwestern medical Center
3. Distribution of Editorial Board Members All together 65 Members 3 Editors-in-Chief 1 Associate Editor-in- Chief 2 Associate Editors 59 Editorial Board
4. Number of Published Articles (results by year) 90 67.5 45 22.5 86 articles published in 2016. Number of articles has been increasing every year. 0 2012 2013 2014 2015 2016
5. Diverse Types of Article Published in 2016 Editorial 14% Meet the Professor 5% Others 5% Guideline 2% Original & Review Articles 73% In 2016, CCO has published 86 manuscripts, among which there are 61 review articles and original articles. Other article types include Editorial, Guideline, Meet the Professor, etc.
6. Distribution of Corresponding Authors in 2016 Corresponding authors of 86 articles published in 2016 come from 15 countries with 43 % of them from USA.
7. Citations in 2016 (results by month) 400 300 200 100 Number of total citation has significantly increased to 304 in 2016. 0 Feb. Apr. Jun. Aug. Oct. Dec. Note: Data were collected from Web of Science Core Collection (Feb. 2016- Dec. 2016)
8. Website Visits in 2016 All together 79,242 visitors. Readers who visited CCO website in 2016 were from diverse countries, with the majority from the USA, followed by the China, UK and India. Other countries include China, India, UK, etc. Note: Data were collected from Google Analytics (Jan. 10th, 2017)
9. Most Cited Articles Published in 2016 Article Type Title Review Article Gallbladder cancer: South American experience Review Article Genetic and epigenetic landscape of nasopharyngeal carcinoma Review Article Review Article Review Article Proton therapy for nasopharyngeal carcinoma Contemporary management of ductal carcinoma in situ and lobular carcinoma in situ MicroRNAs in nasopharyngeal carcinoma Note: Data were collected from Web of Science (Jan. 10th, 2017)
0. Focused Issues Published in 2016 Focused Issue(V5N2) Nasopharyngeal Carcinoma Joseph Tien Seng Wee,MD Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore. Yoke Lim Soong, MD Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore. Melvin Lee Kiang Chua, MD Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore.
Focused Issue(V5N3) Management of Breast Cancer Ning Liao, MD, PhD Guangdong General Hospital and Cancer Center, Guangzhou, China Kelly K. Hunt, MD, FACS University of Texas MD Anderson Cancer Center, Houston, Texas, USA Charles M. Balch, MD, FACS University of Texas MD Anderson Cancer Center, Houston, Texas, USA; University of Texas Southwestern Medical Center, Dallas, Texas, USA
Focused Issue(V5N4) Proton Therapy Minesh Mehta, MD Department of Radiation Oncology, Miami Cancer Institute, Miami, FL, USA Arpit Chhabra, MD Department of Radiation Oncology, The University of Maryland School of Medicine, Baltimore, Maryland, USA
Focused Issue(V5N5) Biliary Cancer Ghassan K. Abou-Alfa, MD Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
1. Upcoming Focused Issues in 2017 Focused Issue Immunotherapy of Cancer Jon Wigginton, MD Senior Vice President of Clinical Development, MacroGenics, Inc, University of Michigan, USA. Bernie Fox, Ph.D Laboratory of Molecular and Tumor Immunology, EACRI; MMI and Env and Biomolec systems,leader, of Tumor Immunology Focus Group, OHSU Cancer Institution, USA.
Focused Issue Pancreatic Cancer Lei Zheng, MD, PhD The Johns Hopkins University School of Medicine, USA Eileen M. O Reilly, MD Department of Medicine, Memorial Sloan- Kettering Cancer Center, New York, New York, USA
Focused Issue Contemporary and future treatment for meningioma Matthias Preusser, MD Department of Medicine I, Comprehensive Cancer Center-CNS Unit, Medical University of Vienna, Vienna, Austria Priscilla Brastianos,MD Massachusetts General Hospital, USA Helen Alice Shih, MD Associate Medical Director - Francis H. Burr Proton Therapy Center, USA
Focused Issue Neuro-oncology Wenyin Shi, MD Department of Radiation Oncology Thomas Jefferson University Philadelphia, PA, USA
Focused Issue Advances in stereotactic radio surgery s Kevin Lee Min Chua, MBBS, FRCR Division of Radiation Oncology, National Cancer Centre Singapore, Singapore Duke-NUS Graduate Medical School, Singapore. David Tan Boon Harn, MBBS, FRCR Consultant Radiation Oncologist Division of Radiation Oncology National Cancer Centre Singapore, Singapore Duke-NUS Graduate Medical School, Singapore Simon S. Lo, MD, FACR Professor and Vice Chair for Strategic Planning Department of Radiation Oncology University of Washington School of Medicine Seattle, WA, USA
12. International Meeting The China-America Summit Forum on Breast Cancer was held in Guangzhou, China from June 17th to June 18th. CCO Editorial Office joined this splendid academic feast to meet our editorial board members, reviewers, authors and readers.the Focused Issue on Breast Oncology published in CCO has been translated into Chinese and distributed to attendees there.
3. Introduction of the Publisher AME Our Publisher AME Publishing Company www.amegroups.com Registered in Hong Kong 30+ peer-reviewed journals 2 indexed in SCIE 16 indexed in PubMed/PMC/ MEDLINE 13 indexed in ESCI